`UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549



Form 10-QSB


(Mark One)

 [X]     QUARTERLY  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the quarter year ended June 30, 2001.

 [  ]     TRANSITION  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the transition period from _______ to ________


Commission File Number: 2-89616

Consolidated Medical Management, Inc.
(Exact name of Registrant as specified in charter)


Montana                                            82-0369233
State or other jurisdiction of                IRS Employer I.D. No.
incorporation or organization

200 Lafayette #777, Baton Rouge, LA                    70801
(Address of principal executive offices)            (Zip Code)


Issuer's telephone number, including area code:           (225) 275-3857


Check whether the Issuer (1) has filed all reports required to be filed by
section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. (1) Yes [X]
No [  ]     (2) Yes [X]   No [  ]


State the number of shares outstanding of each of the Issuer's classes of
common equity as of the latest practicable date:  At  August 16, 2001, there
were 10,626,347 common shares of the Registrant outstanding.






Consolidated Medical Management, Inc.
Baton Rouge, Louisiana



Table of Contents


                                                                    Page
Part I -  Financial Information
Item 1.   Financial Statements
          Report of Independent Accountant                              2
          Consolidated Balance Sheets                                   3
          Consolidated Statements of Operations                         4
          Consolidated Statements of Cash Flows                         5
          Notes to Consolidated Financial Statements                    6

Item 2.   Management's Discussion and Analysis
 of Financial  Condition and Results of Operation                      11

Part II -     Other Information

Item 2.       Change in Securities                                     13

Item 5.       Other Information                                        13

Item 6.       Exhibits and Reports on Form 8-K                         13

Signature                                                              14





Part I

Financial Information

Item 1.  Financial Information

The consolidated financial statements for Consolidated Medical Management,
Inc. (the Company) included herein are unaudited but reflect, in management's
opinion, all adjustments, consisting only of normal recurring adjustments,
that are necessary for a fair presentation of the Company's financial position
and the results of its operations for the interim periods presented.  Because
of the nature of the Company's business, the results of operations for the
three months ended June 30, 2001 are not necessarily indicative of the results
that may be expected for the full fiscal year.  The financial statements
included herein should be read in conjunction with the financial statements
and notes thereto included in the Company's Annual Report on Form 10-KSB for
the year ended December 31, 2000 (2000 Form 10-KSB).




1


REPORT OF INDEPENDENT ACCOUNTANT



To the Board of Directors
Consolidated Medical Management, Inc.
(A Montana Corporation)
Baton Rouge, Louisiana


We have made a review of the consolidated balance sheet of Consolidated
Medical Management, Inc. as of June 30, 2001,and the related consolidated
statements of operations and cash flows for the three and six months period
ended June 30, 2001 and 2000, in accordance with the standards established by
the American Institute of Certified Public Accountants.  These financial
statements are the responsibility of the Company's management.

A review of interim financial information consists principally of obtaining an
understanding of the system for the preparation of interim financial
information, applying analytical review procedures to financial data, and
making inquiries of persons responsible for financial and accounting matters.
It is substantially less in scope than an audit in accordance with generally
accepted auditing standards,  the objective of which is the expression of an
opinion regarding the financial statements taken as a whole.  Accordingly, we
do not express such an  opinion.

Based on our review, we are not aware of any material modifications that
should be made to the consolidated financial statements referred to above for
them to be in conformity with generally accepted accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet as of December 31, 2000, and the
related consolidated statements of income, cash flows and changes in common
shareholders' equity (deficit) for the year then ended (not presented herein);
and in our report dated April 30, 2000, we expressed a qualified opinion on
those financial statements.  In our opinion, the information set forth in the
accompanying balance sheet as of June 30, 2001, is fairly stated in all
material respects in relation to the balance sheet from which it has been
derived.





                                Clyde Bailey P.C


San Antonio, Texas
August  16, 2000

2



CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Balance Sheet
(Unaudited)

ASSETS
                                                  June 30, 2001          December 31, 2000
Current Assets
     Cash                                               $441                 $1,724

               Total Current Assets                      441                  1,724

Property and Equipment, net                                -                 17,415

               Total Assets                             $441                $19,139

LIABILITIES AND STOCKHOLDERS' EQUITY
(DEFICIT)

Current Liabilities
     Notes Payable-Current Portion                   $27,647                $25,767
     Accounts Payable                                154,314                275,300
     Accrued Expenses                                155,666                115,372
     Convertible Debentures                          465,000                465,000
          and Notes Payable-Current Portion

               Total Current Liabilities             802,627                881,439

     Notes Payable - Long Term Portion                54,726                 54,726
     Capital Lease Obligation Payable                      -                      -
          Long-Term Portion

               Total Long-Term Liabilities            54,726                 54,726

               Total Liabilities                    $857,353               $936,165

Commitments and Contingencies:

Stockholders' Equity
     Common Stock                                    $10,626                $15,026

     Additional Paid-in-Capital                    2,516,111              2,915,711
     Retained Earnings (Deficit)                  (3,383,649)            (3,847,763)

          Total Stockholders' Equity (Deficit)      (856,912)              (917,026)

          Total Liabilities and Stockholders'
           Equity (Deficit)                             $441                $19,139



3



CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Statement of Operations
(Unaudited)



                                             Three Months ended June 30,       Six Months ended June 30,
                                                  2001          2000               2001          2000

Revenues                                         $-              $373                $-          $76,660

Operating Expenses
     Personnel Costs                              -            49,350                 -          118,278
     Consulting                                   -             8,932                 -           35,667
     Depreciation and Amortization                -             8,087                 -           16,173
     Legal and Professional                     2,800           6,000            18,800           42,225
     Office Expense                               913               -             2,342           12,818
     Occupancy                                    -             5,050             1,880           11,164
     Transportation                               -                 -                 -                -

     Total Operating Expenses                  $3,713         $77,419           $23,022         $236,325

Income (Loss) from Operations                  (3,713)        (77,046)          (23,022)        (159,665)

Other Income (Expenses)
     Other                                        -                 -           528,387                -
     Interest Expense                         (20,261)        (21,944)          (41,251)         (42,743)
     Interest Income                              -                 5                 -            1,817

                                              (20,261)        (21,939)          487,136          (40,926)

Income (Loss) before Income Taxes            $(23,974)       $(98,985)         $464,114        $(200,591)

Income Tax Expense                                -                 -                 -               -

Net Income (Loss)                            $(23,974)       $(98,985)         $464,114        $(200,591)

Net Income (Loss) per Share                   $(0.002)        $(0.009)           $0.044          $(0.019)


4

CONSOLIDATED MEDICAL MANAGEMENT, INC.
Consolidated Statement of Cash Flows
(Unaudited)

                                                                      Six Months ended June 30,
                                                                        2000               2000

Cash Flows from Operating Activities:
     Net Income (Loss)                                               $464,114            $(200,591)
     Adjustments to Reconcile Net Income (Loss) to

     Net Cash Provided by Operating Activities:
               Depreciation and Amortization                                -               16,172
     Non Cash Consulting and Services Paid by Stock Issue                   -                4,000
               (Increase) Decrease in Receivables                           -              (53,394)
               (Increase) Decrease in Accounts Payable               (120,986)              61,977
               (Increase) Decrease in Interest Payable                 40,294             -
               (Increase) Decrease in Accrued Expenses                      -               23,148

      Net Cash Provided (Used) by Operating Activities               $383,422            $(148,688)


      Cash Flows from Investing Activities:


          Assets Disposed                                              17,415            $-
                                                                            -             -

      Net Cash Provided (Used) by Investing Activities                $17,415            $-


      Cash Flows from Financing Activities:

          Increase in Short-Term Debt                                   1,880             -
          Common Stock                                               (404,000)             140,390

      Net Cash Provided (Used) by Financing Activities              $(402,120)            $140,390

      Net Increase (Decrease) in Cash                                 $(1,283)             $(8,298)

      Cash, Beginning of period                                         1,724               25,540

      Cash, End of period                                                $441              $17,242

      Supplemental Disclosure of Cash Flow Information
          Cash Paid During the Period for:
               Interest                                                    $-            $-
               Income Taxes                                                $-            $-


5


Consolidated Medical Management, Inc
NOTES TO FINANCIAL STATEMENTS




Basis of Presentation

The unaudited financial statements included herein have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-QSB and Item 301(b) of
Regulation S-B. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements.  In the opinion of management, all adjustments
(consisting of normal recurring accruals) considered necessary for a fair
presentation have been included.  Operating results for the three and six
months ended June 30, 2001 and 2000 are not necessarily indicative of the
results that may be expected for the year ended December 31, 2001. The
December 31, 2000 balance sheet was derived from audited financial statements,
but does not include all disclosures required by generally accepted accounting
principles. Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and
regulations relating to interim consolidated financial statements. For further
information, the statements should be read in conjunction with the financial
statements and notes thereto included in the Company's registration statement
on Form 10KSB.

The Company adopted Financial Accounting Standards  (SFAS) No.  128,
"Earnings Per Share," which simplifies the computation of earnings per share
requiring the restatement of all prior periods. Basic earnings per share are
computed on the basis of the weighted average number of common shares
outstanding during each year. Diluted earnings per share are computed on the
basis of the weighted average number of common shares and dilutive securities
outstanding.  Dilutive securities having an anti-dilutive effect on diluted
earnings per share are excluded from the calculation.

Organization

The  Company (formerly Golden Maple Mining and Leaching Co., Inc.) was
incorporated under the laws of the State of Montana on August 13, 1981.  The
Company ceased its mining operations in 1985, and discontinued all business
operations in 1990.  On May 23, 1998, the Company acquired all the common
stock of Consolidated Medical Management, Inc. (a private Louisiana
corporation, hereafter sometimes referred to as "CMMI-LA" or "subsidiary") in
a stock for stock exchange transaction, whereupon, CMMI-LA became a wholly
owned subsidiary of the Company.  These financial statements reflect the
financial condition and results of operations for the consolidated Company,
retroactively stated as if the acquisition had occurred at the beginning of
the current fiscal period.



6


Consolidated Medical Management, Inc.
NOTES TO FINANCIAL STATEMENTS

The subsidiary provided management services for home healthcare providers
predominately in southern Louisiana.  The Company's subsidiary, Independent
Diagnostic Services, Inc., provides diagnostic ultrasound imaging services to
physician offices, clinics, hospital and skilled nursing facilities, and also
provides mobile laboratories that will enable services to be provided for
communities with limited access to technologists, hospitals and diagnostic
laboratories.  The Company has formed a subsidiary, Psychiatric Medical
Services, Inc. ("PMSI") to operate a partial-unit mental services hospital in
an existing hospital environment.  As of December 31, 1999,  all operating
activities has ceased due to the fact that a contract with a major customer
was cancelled in  August of 1999.

Principles of Consolidation

The consolidated financial statements include the accounts of Consolidated
Medical Management, Inc. (a Montana Corporation), and its subsidiaries,
Independent Diagnostic Services, Inc. and Psychiatric Management Services,
Inc.. The Company and its subsidiaries provide health care services
specializing in mobile diagnostic imaging and the operation of a part-hospital
psychiatric unit and therefore extends credit to the health care providers
involved with the patients served.

Note 1  -  Summary of Significant Accounting Policies

Accounting policies of the Company conform with the generally accepted
accounting principles and reflect practices appropriate to the industry in
which it operates.  The significant policies are summarized below.

Property, Equipment and Depreciation  - Due to the Company's lack of
business, the Company has disposed of all assets it owned as of March 31,
2001. The resulting value of  $17,415 has been written off to Other Income and
Expenses for the current quarter.

Risks and Uncertainties  -  The preparation of financial statements in
conformity with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the
date of financial statements and the reported amounts of revenues and expenses
during the reported period.  Actual results could differ from those estimates.



7



Consolidated Medical Management, Inc.
NOTES TO FINANCIAL STATEMENTS

Note 2  -  Notes Payable


Note payable to GE Capital, financing the phone system,
in the original amount of $ 10,222, dated
September 16, 1997,  payable in thirty-nine installments
of $341 with  interest at 12.5%, secured by a pledge of
the phone system                                    $        5,640

Six  (6) notes payable to Spectrum Financial, Inc., a
related party of the Company, dated September 29,1998,
due July 29, 2000, interest at 10%, payable on
maturity, unsecured                                         76,733

Total Notes Payable                                         82,373
     Less Current Portion                                  (27,647)
     Long Term Portion                              $       54,726

        Maturities of Notes Payable over the next five years are:

               2001                                 $       82,373
               2001 and thereafter                              -0-
                                                    $       82,373


 Note 3  -  Convertible Debentures and Notes Payable

The Company issued convertible debentures in 1998 that are subordinated to
bank debt and secured leases.  The debentures are otherwise unsecured but are
given a preference over unsecured debt. The debentures include interest at
fifteen (15%) percent, interest is payable in monthly installments.  Each
debenture has a conversion right for each holder to convert the debenture
principal to shares of the Company's common stock at the greater of $2.50 per
share or sixty (60%) percent of the bid price, whichever is greater on the
date of conversion.  Accrued interest and any principal amount not converted
to shares of stock will be paid in cash at conversion.  The company had issued
and outstanding $190,000 in debentures.  The debentures are due one year from
date of issue. All debentures issued in 1998 were due in 1999.

The Company issued convertible promissory notes payable in 1998.  The notes
are unsecured and include interest at ten (10%) percent, interest is payable
in monthly installments.  Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's
discretion.  Accrued interest and any principal amount not converted to shares
of stock will be paid in cash at conversion. The company had issued and
outstanding $325,000 in notes payable.  The notes were due July 31, 1999.

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.  In exchange,
Spectrum will then receive an unsecured note payable from the Company (see
Note 7) for the face amount of the debenture surrendered.


     Total Convertible Debentures and Notes Payable          $       465,000
     Less: Current Portion                                          (465,000)
     Long-Term Portion                                       $            -0-

Note 4  -  Common and Preferred Stock

Common Stock

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of June 30, 2001.  As of June 30, 2001, the Company had
10,626,347 shares issued and outstanding, respectively.

Previously the Company had issued 4,000,000 shares of common stock to Douglas
Kemp, its President and CEO. On May 16, 2001, the Company approved a
resolution to cancel those shares and to reverse out the accrual of his unpaid
salary from the year 2000 and 2001.

The Company also cancelled the 400,000 shares of common stock to Jack London
and reversed out the $400,000 in Acquisition Costs that was written off to
Other Income as of June 30, 2001.

Preferred Stock

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $ 0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00
Preferred Stock," with the number of authorized shares set at 1,079,957
shares.  As of March 31, 2001 there are no shares issued and outstanding.

Dividends - Dividends are non-cumulative, however, the holders of such series,
in preference to the holders of any common stock, shall be entitled to
receive, as and when declared payable by the Board of Directors from funds
legally available for the payment thereof,  dividends in lawful money of the
United States of America at the rate per annum fixed and determined as herein
authorized for the shares of such series, but no more, payable quarterly on
the last days of March, June, September, and December in each year with
respect to the quarterly period ending on the day prior to each such
respective dividend payment date.  In no event shall the holders of either
series receive dividends of more than percent (1%) in any fiscal year.  Each
share of both series shall rank on a party with each other share of preferred
stock, irrespective of series, with respect to dividends at the respective
fixed or maximum rates for such series.

Conversion provisions- Any holder of either series may convert any or all of
such shares into shares of common stock of the Company at any time. Said
shares shall be convertible at a rate equal to three (3) shares of common
stock of the Company for each one (1) share of Series "A" of $ 12.50 Preferred
Stock.  The Series "A" $12.50 Preferred Stock shall be convertible, in whole
or in part, at any time after the common stock of the Company shall maintain
an average bid price per share of at least $12.50 for ten (10) consecutive
trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for
ten (10) consecutive trading days.

The preferential amount payable with respect to shares of  either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share,  plus
the amount of any dividends declared and unpaid thereon.


Note  5  -  Commitments and Contingencies

There exists some contingencies that the Company may be exposed to additional
liabilities that are not recorded on the Balance Sheet. One, the Company
issued notes payable to two Organizations that were to be acquired. The
balance of the notes payable is $438,000, but the Company has refused to honor
these notes because the acquiring Organizations did not honor their
contractual agreement to provide necessary information to the Company.
Secondly, the Company in indebted to the Organization that the Company had
subleased the imaging equipment. Since the Organization picked up three of the
four units, the Company removed the liabilities from its Balance Sheet. Total
contingent liabilities from the equipment leases that was written off is $
211,370.

The Company had previously agreed to pay Douglas Kemp salary for 24 months
after his dismissal. The Company does not plan to honor this agreement due to
non-performance of his employment contract.


Note  10 -  Other Income and Expenses

Details of the Other Income and expenses for the six months ended June 30,
2001 is as follows:

          Reversal of Salary Accrual for Douglas Kemp          $ 141,802
          Cancellation of Common Shares for Douglas Kemp           4,000
          Disposal of Fixed Assets                               (17,415)
          Cancellation of Common Shares for Jack London          400,000

          Total                                               $  528,387





10




Item 2.    Management's Discussion and Analysis of Financial Condition
              and Results of Operations

The following discussion and analysis should be read in combination with
Management's Discussion and Analysis of Financial Condition and Results of
Operations in Item 6 of the 2000 Form 10-KSB, the financial statements and
notes contained in Item 7 of the 2000 Form 10-KSB and the interim financial
statements and notes thereto contained elsewhere in this Report.

Certain statements set forth in this discussion and analysis of financial
condition and results of operations including anticipated store openings,
planned capital expenditures and trends in or expectations regarding the
Company's operations constitute "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
statements are based on currently available operating,  financial and
competitive information and are subject to various risks and uncertainties.
Actual future results and trends may differ materially depending on a variety
of  factors as set forth herein.


RESULTS OF OPERATIONS

    -     For the Six Period Ended June 30, 2000

The Company recognized net loss of ($200,591), (with loss per share of
($0.019) per common share) for the six month period.  During this period , the
Company has only limited operations due to the fact that contracts were lost
with a major customer in 1999 and they only have one piece of equipment to
perform medical treatments.  The Company is inactive at the present time.

For the three-month period ended June 30, 2000,  the Company incurred
operating costs associated with the production of revenue totaling $77,419.
The most significant elements of operating expenses are personnel costs
totaling $49,350 for the quarter.  Personnel costs include professional wages
of the personnel who deliver the health-care services required by the
contracts and related administrative salaries and benefits.  In the quarter,
the Company incurred legal and professional fees totaling $6,000 primarily
associated with  filings and legal matters on stock related issues common
share).  During this period , the Company has only limited operation due to
the fact that contracts were lost with a major customer in 1999 and they only
have one piece of equipment to perform medical treatments.




11


     -     For the Six-Month Period Ended June 30, 2001

The Company recognized net income of $464,114, (with income per share of
$0.044 per common share). The net income is related primarily to the
cancellation of common stock and reversal of salary accrued in 2000 As of June
30, 2001, the Company has no operations in place.

There were no operating revenues during the quarter and the only operating
expenses were professional fees and $4,442 in office and occupancy expenses.


FINANCIAL CONDITION

Liquidity and Capital Resources

As of March 2001, the Company cancelled 4,400,000 shares of common stock and
recognized a $404,000 used from Financing Activities.

The Company has a cash balance of $441 as of June 30, 2001 and a working
capital deficit of ($802,186)

The Company's accounts payable and accrued expenses total $154,314 as of June
30, 2001.   The Company's obligations under these accounts have aged since
December 31, 2000, with $154,314 of these amounts owed for more than ninety
days.




12



Part II

Other Information

Item 2.    Changes in Securities and Use of Proceeds

Since the end of the fiscal year ended December 31, 2000, and through the end
of  the quarter ended March 31, 2001,  the Company  has not issued any shares
of common stock of the company without registration under the Securities Act
of 1993.

All of the aforesaid securities set forth immediately above were issued
without registration under the Act by reason of the exemption from
registration afforded by the provisions of Section 4(2) thereof, as
transactions by an issuer not involving any public offering, each recipient of
securities having delivered appropriate investment representations to
Registrant with respect thereto and having consented to the imposition of
restrictive legends upon the certificates evidencing such securities.  No
underwriting discounts of commission were paid in connection with such
issuances.

Item 5.    Other Information
(a)     The following table sets forth the current executive officers and
directors of the Company:
                                      Director
Name                     Age          Position(s)                    Since
Peggy D. Behrens          44          Director and Secretary          1998
Lynn Simon, M.D.          49          Director                        1998

(b) There are no significant employees other than executive officers above.

(c) There are no family relationships among directors or executive officers of
the Company.


Item 6.    Exhibits and Reports on Form 8-K

(a)     Exhibits.  The following exhibits are included as part of this report.

Exhibit  No          Description of Exhibit
     None

(b)     No reports on Form 8-K were filed during the quarter covered by this
report.





13



SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Consolidated Medical Management, Inc.



By - Peggy Behrens - Secretary
     (Principal Accounting Officer)

Date: August 28, 2001





14`